Zurich, September 23, 2015 – Phytoceuticals Ltd., a life science company focusing on the development and marketing of plant-based wound care products, today announced that the Company has received approval from the Korean Food and Drug Administration (KFDA) to market 1 PRIMARY WOUND DRESSING® in South Korea.

To develop the Korean market, Phytoceuticals Ltd. has established a distribution partnership with PUBLICMED, a company specialized in the import and sales of high end wound care products for medical professionals and patients.

Eduardo Theiler, CEO of Phytoceuticals Ltd., comments on this new authorization: “This marketing approval in South Korea is a fantastic milestone and success for our company. We are proud to be able to offer our product in Asia's third largest medical device market.”

“Bringing such a new and effective natural product to the Korean market represents an amazing opportunity for our company. We have an existing sub-distributor network and will quickly promote the use of “1” through our channels and make “1” available to medical professionals and patients”, said Minkoo Jeong, CEO of PUBLICMED.

# # # # #

AuthorEduardo Theiler